Baird Financial Group
ANIK icon

Baird Financial Group’s Anika Therapeutics ANIK Stock Holding History

Baird Financial Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-135,154
Closed -$5.85M – 1853
2021
Q2 		$5.85M Buy
135,154
+380
+0.3% +$16.2K 0.02% 549
2021
Q1 		$5.5M Sell
134,774
-1,526
-1% -$57.9K 0.02% 549
2020
Q4 		$6.17M Sell
136,300
-103,067
-43% -$3.91M 0.02% 489
2020
Q3 		$8.47M Buy
239,367
+4,917
+2% +$178K 0.03% 392
2020
Q2 		$8.85M Buy
234,450
+113,328
+94% +$3.73M 0.03% 370
2020
Q1 		$3.5M Sell
121,122
-55,253
-31% -$2.23M 0.02% 523
2019
Q4 		$9.14M Sell
176,375
-2,038
-1% -$118K 0.03% 392
2019
Q3 		$9.79M Sell
178,413
-868
-0.5% -$44.6K 0.04% 356
2019
Q2 		$7.28M Buy
179,281
+10,323
+6% +$376K 0.03% 422
2019
Q1 		$5.11M Buy
168,958
+158,906
+1,581% +$5.44M 0.03% 440
2018
Q4 		$338K Sell
10,052
-89,412
-90% -$3.23M ﹤0.01% 1076
2018
Q3 		$4.16M Buy
99,464
+8,949
+10% +$354K 0.03% 484
2018
Q2 		$2.9M Buy
90,515
+9,318
+11% +$384K 0.02% 561
2018
Q1 		$4.04M Buy
81,197
+32,777
+68% +$1.85M 0.03% 464
2017
Q4 		$2.61M Buy
48,420
+839
+2% +$46.4K 0.02% 550
2017
Q3 		$2.76M Sell
47,581
-416
-0.9% -$21.7K 0.02% 541
2017
Q2 		$2.37M Buy
+47,997
New +$2.21M 0.02% 563

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Baird Financial Group's ANIK Position: Q3 2021 in Review

Baird Financial Group sold out of Anika Therapeutics (ANIK) in Q3 2021, closing a stake of 135,154 shares — an estimated $5.85M sold.

Baird Financial Group first reported a position in ANIK in Q2 2017 and held it in 17 quarters. The position peaked at $9.79M in Q3 2019. 131 funds tracked by Wall St. Rank hold ANIK as of Q3 2021.

  • Baird Financial Group reported no remaining Anika Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Baird Financial Group sold 135,154 Anika Therapeutics shares in Q3 2021, an estimated $5.85M.
  • Baird Financial Group first reported a position in Anika Therapeutics in Q2 2017 and held it in 17 quarters.
  • Baird Financial Group's Anika Therapeutics position peaked at $9.79M in Q3 2019.
  • 131 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2021.

Based on Baird Financial Group's 13F filing for Q3 2021, filed 12 Nov 2021.